Search for: "Johnson v. Bristol-Myers Squibb Company"
Results 1 - 20
of 30
Sorted by Relevance
|
Sort by Date
20 Jun 2017, 1:15 pm
Bristol-Myers Squibb Company v. [read post]
9 Jul 2019, 6:54 pm
The ruling relied heavily upon the Supreme Court’s 2017 decision in Bristol Myers Squibb v. [read post]
26 Jun 2015, 11:30 am
For whatever reason, California courts have seemed open to hosting plaintiffs from everywhere, a point well exemplified by our Hotel California post discussing the now-vacated Bristol-Myers Squibb Co. v. [read post]
26 May 2007, 11:26 pm
Bristol-Myers Squibb and Sa nofi-Aventis, which co-market the widely used drug, defended the patent from a challenge by Canadian generic drugmaker Apotex, which briefly flooded the market with copycat Plavix tablets last summer. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
8 Jun 2023, 7:43 am
Examples of the latter include the Bristol-Myers-Squibb – Celgene merger in 2018, and the Merck-Wyeth merger of 2009. [read post]
3 Feb 2010, 2:00 am
Johnson & Johnson Inc. et al. [read post]
26 May 2015, 7:42 am
Bristol-Myers Squibb Co., 2011 WL 4708850 (D. [read post]
29 Jul 2009, 6:45 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Tri-Cyclen Lo (Norgestimate, Ethinyl estradiol) – US: Johnson & Johnson, Teva settle patent infringement proceedings – the reverse of a reverse payment? [read post]
18 Jun 2012, 1:38 pm
In the back of the Court’s mind, of course, was January’s $99 million settlement by Novartis for overtime claims by its pharmaceutical sales representatives following the Second Circuit’s 2010 decision in In re Novartis Wage & Hour Litig., and similar pending cases against Johnson & Johnson, Merck Co. and Bristol-Myers Squibb. [read post]
3 Mar 2009, 5:55 am
After plaintiff reported the loss, defendant Erie Insurance Company began an investigation into the claim. [read post]
15 Oct 2008, 3:02 pm
Much of the lobbying efforts were aimed at Sheldon Bradshaw, who had succeeded Daniel Troy as FDA chief counsel in April 2005.AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline,… [read post]
2 Jun 2011, 12:46 pm
Squibb & Sons, Inc. v. [read post]
27 Jan 2017, 12:52 pm
The court also granted last Thursday in the much less colorful two-time relist Bristol-Myers Squibb Company v. [read post]
26 Jun 2015, 8:05 am
Bristol-Myers Squibb, CN 91-21770, Tx Dist. [read post]
24 Dec 2014, 5:00 am
Hood v. [read post]
27 Feb 2009, 7:00 am
(Techdirt) How companies can cash in on innovations and patents (IP Frontline) International Property Rights Index 2009 - New report identifies world’s most IP-friendly country, but trade marks are ignored (IAM) What do clients want? [read post]
26 Feb 2015, 5:00 am
In Henderson, the plaintiff failed to prove negligence but claimed that “‘even if the Drug Company was not negligent . [read post]
5 Nov 2007, 12:58 pm
Bristol-Myers Squibb, 97 F. [read post]
10 Sep 2012, 7:28 pm
Mich. 1996); Bristol-Myers Squibb Co. v. [read post]
